Imatinib Mesylate

CAS 220127-57-1

Also known as: Imatinibmesylate Glivec

Imatinib mesylate can inhibit BCR ABL tyrosine kinase in vitro and in vivo, selectively inhibit the proliferation and induce apoptosis of BCR ABL positive cell lines, chronic myeloid leukemia and fresh cells from patients with acute lymphoblastic leukemia. In addition, imatinib mesylate can also inhibit the tyrosine kinase of PDGF receptor, SCF and c-kit receptor, thus inhibiting the cell behavior mediated by PDGF and stem cell factor.

Request a Quote
Category: Pharmaceutical Chemicals APISubcategory: Antineoplastic Drugs APIProduct ID: imatinib-mesylate-220127-57-1
Payment & Shipping Terms Supply Capacity
Payment Terms: T/T, WU Production Capacity: 1000kg/year
Min. Order: 1 Gram Packing: according to the customer's requirements
Means of Transport: Ocean, Air, Land Delivery Date: 7 days

Imatinib mesylate

CAS 220127-57-1

Imatinib mesylate can inhibit BCR ABL tyrosine kinase in vitro and in vivo, selectively inhibit the proliferation and induce apoptosis of BCR ABL positive cell lines, chronic myeloid leukemia and fresh cells from patients with acute lymphoblastic leukemia. In addition, imatinib mesylate can also inhibit the tyrosine kinase of PDGF receptor, SCF and c-kit receptor, thus inhibiting the cell behavior mediated by PDGF and stem cell factor.

We can customize according to customer's requirement

if you have any question pls mail us or call us.

CAS Number 220127-57-1
Place of Origin Zhejiang,China (Mainland)
Brand Name MOSINTER
CAS No. 220127-57-1
Purity 99% MIN
Request a quote

Send an inquiry for Imatinib Mesylate

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

×
MOSINTER chemical operations

Request a Quote

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

MOSINTER GROUP